We demonstrated that Plin5−/− mice present differential hepatic lipid accumulation mostly by regulating LD formation and size, since their distribution was different in our NAFLD and NAFLD-HCC models (Fig. 3). Here, PLIN5 is linked to metabolic dysfunction-associated steatotic liver disease.